Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 17
- +1 vs. Q1 2023
- Portfolio value
- $709.3M
- +$127.8M (+22.0%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| AXSMAxsome Therapeutics, Inc. | COM | 2,344,980 | $168.5M | 23.8% | +333,333+16.6% | Added | History |
| NUVLNuvalent, Inc. | COM | 2,884,492 | $121.6M | 17.1% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 6,029,592 | $113.8M | 16.0% | +6,029,592 | New | History |
| ELVNEnliven Therapeutics, Inc. | COM | 2,124,625 | $43.4M | 6.1% | +199,687+10.4% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 3,558,975 | $42.1M | 5.9% | +800,000+29.0% | Added | History |
| MRUSMerus N.V. | COM | 1,482,405 | $39.0M | 5.5% | +1,107,970+295.9% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,369,623 | $32.6M | 4.6% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 73,526 | $28.7M | 4.0% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 1,416,998 | $24.1M | 3.4% | 00.0% | Unchanged | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 2,040,000 | $17.9M | 2.5% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 1,901,397 | $15.8M | 2.2% | 00.0% | Unchanged | History |
| KODKodiak Sciences Inc. | COM | 1,985,245 | $13.7M | 1.9% | +1,985,245 | New | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,064,964 | $13.4M | 1.9% | 00.0% | Unchanged | History |
| TRVITrevi Therapeutics, Inc. | COM | 5,190,360 | $12.4M | 1.7% | −506,155−8.9% | Reduced | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 704,459 | $9.92M | 1.4% | +704,459 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 381,939 | $8.07M | 1.1% | −2,745,490−87.8% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM | 9,460,540 | $4.26M | 0.6% | +9,460,540 | New | History |
Sold out since Q1 2023 (3)
Positions held at the end of Q1 2023 that are gone from this filing.